SPINK1 and hepatocellular carcinoma: Analyses of the acquired experimental data provided more understanding on SPINK1. We therefore further explored the likelihood of SPINK1 as a target molecule in targeted therapeutics for HCC, as we verified its targeting exhibited during HCC progression and development.